"Patent Expiration Countdown: 5 Strategies to Secure Your Pharma Company’s Future
As the pharmaceutical industry’s patent expiration calendar looms large, executives must navigate a complex landscape of generic competition and regulatory hurdles. …

"The Patent Paradox: As AI Takes Center Stage in Drug Discovery, Who Owns the Breakthroughs?
As artificial intelligence begins to revolutionize the field of drug discovery, a pressing question arises: who will reap the rewards of these groundbreak…

"Breaking Down Barriers: How MRAs Can Revolutionize the Generic Drug Approval Process
In a move that could significantly accelerate the availability of affordable generic medications, pharmaceutical companies are turning to Mutual Recognition Agre…

"The $1 Trillion Question: Can Specialty Generics Bridge the Gap in Access to Life-Changing Medications?
As the pharmaceutical industry grapples with rising costs and stagnant innovation, a quiet revolution is underway. Specialty generics, once a …

"The Future of Medicine is Patent-Protected: How Market Leaders are Securing Their Precision Medicine Innovations
As the precision medicine revolution continues to transform the healthcare landscape, one thing is clear: patent protection is no lon…

"The Secret to Making Generic Medications: A Tale of Precision and Reproducibility
As the pharmaceutical industry continues to grapple with the complexities of generic drug development, one crucial factor stands out: the delicate balance between p…

"The Patent Puzzle: Can AI-Designed Medicines Be Owned by Their Creators?
As the pharmaceutical industry grapples with the potential of generative AI in drug design, a pressing question arises: who owns the rights to a medicine created by artifici…

"The Patent Linkage System is Coming to Canada: What it Means for Patients and Pharmaceutical Companies
A new era of transparency and accountability is dawning on Canada’s pharmaceutical landscape. As of https://www.drugpatentwatch.com/blog/patent…

"The Dragon Stirs: How China’s Pharmaceutical Industry is Igniting a Global Revolution
As the world’s second-largest economy, China has long been a sleeping giant in the pharmaceutical industry. But a new report reveals that the dragon is finally …

"The Quiet Consolidation of Power in American Healthcare
As the pharmaceutical industry grapples with rising costs and shifting market dynamics, a lesser-known player is quietly accumulating influence: Pharmacy Benefits Managers (PBMs).
A new rep…